Palliative Care in Patients with Hematological Malignancies

Area of Science:

• Oncology
• Palliative Care
• Hematology

Background:

• Patients with hematologic malignancies (HM) have significant symptom burden and distress, often comparable to or exceeding other cancer patients.
• Despite high hospitalization rates, HM patients receive specialist palliative care (SPC) or hospice care at half the rate of other cancer patients.
• The focus on life prolongation often overshadows palliative care needs until the final stages of illness.

Purpose of the Study:

• To provide a comprehensive overview of end-of-life care for HM patients.
• To review current data on integrated specialist palliative care (SPC) for HM.
• To identify potential barriers to SPC integration in HM care.

Main Methods:

• This study is a narrative review of existing literature.
• It synthesizes data on the current state of palliative care in HM.
• It examines the effects and barriers of integrated SPC.

Main Results:

• HM patients experience severe symptoms and distress, with a higher likelihood of dying in hospitals.
• Integrated SPC demonstrates high acceptability and positive outcomes, including improved quality of life and reduced psychological distress.
• Key elements like interdisciplinary cooperation and timely SPC referral indicators are frequently missing.

Conclusions:

• Further research is needed to identify HM patients who would benefit most from SPC.
• Developing and evaluating early integrated palliative care models for HM is crucial.
• Establishing these models in routine clinical practice is essential for improving end-of-life care in HM.